The Protocol Review and Monitoring Committee (PRMC) was established at UAMS in 1994 and reviews all clinical studies conducted under the auspices of the Winthrop P. Rockefeller Cancer Institute (Cancer Institute).

All cancer-related clinical protocols must be reviewed and receive full PRMC approval (in addition to IRB approval) before they can be activated and enroll patients. New protocols are approved based on scientific merit, scientific priority, patient availability, and available resources.

 

Contacts for administrative and data management questions, forms, and protocol submission:

Mazin Safar, MD
PRMC Chair
Associate Professor of Medicine
Division of Hematology/Oncology
WPRCI 10th Floor
Mail Slot #508
Phone: 501-686-8511
Email:  safarahmedm@uams.edu

Mary Blaine, CPC
PRMC Administrator
10th Floor Cancer Institute
Mail Slot #724
Phone:  501-686-8274
Email: mcblaine@uams.edu